Literature DB >> 15812449

Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children.

Chaluntorn Preeyasombat1, Peter Bacchetti, Ann A Lazar, Robert H Lustig.   

Abstract

OBJECTIVES: To assess insulin dynamics to oral glucose tolerance testing in obese children, denoting individual contributions of insulin hypersecretion versus resistance to racial and etiopathogenetic specificity. STUDY
DESIGN: We performed 3-hour oral glucose tolerance testing in 113 nondiabetic obese children (age 13.6 +/- 3.1 years; 41 male, 78 female; 37 black, 41 white; 35 with central nervous system [CNS] insult). The corrected insulin response (CIRgp; measuring beta-cell secretion) and the composite insulin sensitivity index (CISI) were computed and log-transformed, and each was modeled in terms of the other, plus race/etiology, age, sex, body mass index z score, glucose tolerance, pubertal status, and geographic location.
RESULTS: A scatterplot of logCIRgp versus logCISI showed that racial and etiopathogenetic groups plotted in different areas. CISI (controlled for CIRgp and other variables) was only 13% lower in blacks than in whites ( P = .32). Conversely, CIRgp (controlled for CISI and other variables) was 49% higher in blacks ( P = .028). CNS insult exhibited a 40% higher CIRgp ( P = .054) and 11% higher CISI ( P = .42) than intact white subjects.
CONCLUSIONS: Insulin hypersecretion and resistance are distinct phenomena in childhood obesity. Insulin hypersecretion appears to be the more relevant insulin abnormality both in obese blacks and in CNS insult.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812449     DOI: 10.1016/j.jpeds.2004.12.014

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Authors:  R H Lustig; F Greenway; P Velasquez-Mieyer; D Heimburger; D Schumacher; D Smith; W Smith; N Soler; G Warsi; W Berg; J Maloney; J Benedetto; W Zhu; J Hohneker
Journal:  Int J Obes (Lond)       Date:  2006-02       Impact factor: 5.095

Review 2.  Pediatric endocrine disorders of energy balance.

Authors:  Robert H Lustig
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

3.  Impaired endothelial function in healthy African-American adolescents compared with Caucasians.

Authors:  Mary M Duck; Robert P Hoffman
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

4.  Population analysis of ethnicity and first-phase insulin release.

Authors:  Lanyi Xie; Robert P Hoffman; Peter Veng-Pedersen
Journal:  Diabetes Res Clin Pract       Date:  2010-05-31       Impact factor: 5.602

5.  Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention.

Authors:  Mark D Deboer
Journal:  Expert Rev Endocrinol Metab       Date:  2011-03

6.  Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.

Authors:  Robert H Lustig; Michele L Mietus-Snyder; Peter Bacchetti; Ann A Lazar; Pedro A Velasquez-Mieyer; Michael L Christensen
Journal:  J Pediatr       Date:  2006-01       Impact factor: 4.406

7.  A clinic-based lifestyle intervention for pediatric obesity: efficacy and behavioral and biochemical predictors of response.

Authors:  Kristine A Madsen; Andrea K Garber; Michele L Mietus-Snyder; Joan K Orrell-Valente; Cam-Tu Tran; Lidya Wlasiuk; Renee I Matos; John Neuhaus; Robert H Lustig
Journal:  J Pediatr Endocrinol Metab       Date:  2009-09       Impact factor: 1.634

8.  The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?

Authors:  Benedikt A Aulinger; Torsten P Vahl; Ron L Prigeon; David A D'Alessio; Deborah A Elder
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-03-15       Impact factor: 4.310

9.  Intraperitoneal fat and insulin resistance in obese adolescents.

Authors: 
Journal:  Obesity (Silver Spring)       Date:  2009-08-27       Impact factor: 5.002

Review 10.  Use of somatostatin analogues in obesity.

Authors:  Themistoklis Tzotzas; Kostas Papazisis; Petros Perros; Gerasimos E Krassas
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.